2024-04-17 04:20:49 ET
Summary
- Dr. Martens' FY2025 outlook shows weakness in the wholesale segment for the upcoming fiscal year after the segment's already very bad FY2024 performance.
- The company's margins are suppressing in the upcoming fiscal year with the lower expected revenues & costs from additional inventory needs.
- Despite the challenges, the brand is still healthy overall, although the trading update worsens my long-term view of Dr. Martens' margins.
- The valuation still seems attractive, as the trading update sent the stock into a wide downfall.
Dr. Martens ( DOCMF ) published a FY2024 trading & FY2025 outlook update on the 16 th of April, showing further signs of weakness in the company’s wholesale segment in the upcoming fiscal year....
Read the full article on Seeking Alpha
For further details see:
Dr. Martens: Weak FY2025 Outlook Due To Continued Challenges, A Cautious Buy